Assignee
NEXTCURE INC
US·3 granted patents·5 pending applications·2 citations·filing 2017–2024
Top patents by PatentIndex Score
8 records- 0177US11390675B2Antibodies for Siglec-15 and methods of use thereofNEXTCURE INC·Filed 2017·Granted Jul 19, 2022·2 cites·3 claims
- 0269US2025084164A1Compositions and methods for modulating lair signal transductionNEXTCURE INC·Filed 2024·Application pending·0 cites
- 0366US2024400678A1Antibodies for siglec-15 and methods of use thereof to treat disuse osteoporosisNEXTCURE INC·Filed 2024·Application pending·0 cites
- 0454US2024352121A1Lair-1 agonistic antibodies and methods of use thereofNEXTCURE INC·Filed 2024·Application pending·0 cites
- 0553US12084495B2Compositions and methods for modulating LAIR signal transductionNEXTCURE INC·Filed 2017·Granted Sep 10, 2024·0 cites·12 claims
- 0651US12286478B2B7-H4 antibodies and methods of use thereofNEXTCURE INC·Filed 2019·Granted Apr 29, 2025·0 cites·16 claims
- 0746US2023357384A1Compositions and methods for modulating flrt3 mediated signal transductionNEXTCURE INC·Filed 2021·Application pending·0 cites
- 0838US2021002373A1KLRG1 Binding Compositions and Methods of Use ThereofNEXTCURE INC·Filed 2019·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →